STOPAREN

This brand name is authorized in Lithuania, Malta

Active ingredients

The drug STOPAREN contains one active pharmaceutical ingredient (API):

1 Cefotaxime UNII 258J72S7TZ - CEFOTAXIME SODIUM

Cefotaxime exerts its action by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thereby inhibiting cell wall synthesis. Read about Cefotaxime

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STOPAREN Powder and solvent for solution for injection		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DD01	Cefotaxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1088477
Country: MT	Medicines Authority	Identifier(s): AA240/01701, AA240/01702